Table 1 Demographic, clinical and angiographic features of the study groups

Age, years

59.3 ∓ 8.6

59.1 ∓ 12.6

Gender, female, n (%)

10 (22.2)

40 (24)

DM, n (%)

14 (30)

53 (31.7)

HT, n (%)

18 (40)

72 (43.1)

CAD, n (%)

8 (17.7)

17 (10.1)

COPD, n (%)

3 (6.6)

12 (7.2)

PAD, n (%)

4 (8.8)

16 (9.5)

Smoking, n (%)

14 (30)

54 (32.3)

LVEF, %

47.2\(\:\pm\:\)11.4

50.4\(\:\pm\:\)12.5

Syntax score-1

18.2\(\:\pm\:6\)0.3

15.8\(\:\pm\:\)7.2

Syntax score-2

35.38\(\:\pm\:7\)0.9

29.70\(\:\pm\:\)9.44

Systolic BP, mmHg

131.5 ∓ 19.6

128.8 ∓ 17.4

Diastolic BP, mmHg

76.3 ∓ 12.5

74.4 ∓ 11.3

HR, beats/min

79.2 ∓ 13.2

74.6 ∓ 12.2

Killip > 1

6 (16.6)

26 (18.9)

Killip 1

30 (83.3)

112 (81.1)

Glucose, mg/dL

117.1 ∓ 50.3

120.4 ∓ 53.7

GFR, mL/min/1,73 m²

75.6 ∓ 24.8

84.0 ∓ 20.6

Total Cholesterol, mg/dL

158.8 ∓ 51.7

171.9 ∓ 47.7

HDL Cholesterol, mg/dL

39 ∓ 7.9

40.1 ∓ 11.3

LDL Cholesterol, mg/dL

88 ∓ 37.7

96.8 ∓ 40.7

Triglyceride, mg/dL

152.1 ∓ 92.1

175.7 ∓ 99.5

hs-Troponin I, ng/L

1969.5(158.6–5709)

1062(69.3-3721.5)

WBC, x10⁹/L

9223 ∓ 4234

10,507 ∓ 3555

Hg, g/dL

13.7 ∓ 2.1

14.2 ∓ 1.7

Neutrophil, x10⁹/L

7006 ∓ 2976

6091 ∓ 4421

Lymphocyte, x10⁹/L

2162 ∓ 955

2480 ∓ 1166

Monocyte, x10⁹/L

803 ∓ 278

748 ∓ 225

Platelet, x10⁹/L

267.3 ∓ 72.8

230.2 ∓ 105.3

MPV, fL

10.5 ∓ 0.85

10.2 ∓ 0.07

PDW, %

12.4 ∓ 1.8

12.2 ∓ 2.0

PCT, %

0.260(0.230–0.297)

0.210(0.190–0.270)

PMI

2585(2278–3000)

2054(1594–2344)

Angiographic Features

Pain to balloon time, hour

5.1 ∓ 3.6

5.4 ∓ 2.1

Infarct related artery

 LAD

20 (55.5)

76 (55)

 LCX

4 (11.1)

17 (12.3)

 RCA

12 (33)

43 (31.1)

Stent count, n

1.56 ∓ 0.81

1.47 ∓ 0.72

Stent length, mm

41.8 ∓ 20.4

39.1 ∓ 19.2

Stent diameter, mm

3.2 ∓ 0.5

3.2 ∓ 0.4